About Polaris Genomics
Polaris Genomics is a company based in Rockville (United States) founded in 2017 by Tshaka Cunningham. Polaris Genomics has raised $800 thousand across 8 funding rounds from investors including Illumina and Sanford Health. Polaris Genomics offers products and services including ADAPT Panel™ and PTS-ID™. Polaris Genomics operates in a competitive market with competitors including Assurex Health, PierianDx, Treos Bio, Circular Genomics and Ignyta, among others.
- Headquarter Rockville, United States
- Founders Tshaka Cunningham
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Trugenomix, Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$800 K (USD)
in 8 rounds
-
Latest Funding Round
$250 K (USD), Debt – Conventional
Aug 19, 2025
-
Investors
Illumina
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Polaris Genomics
Polaris Genomics offers a comprehensive portfolio of products and services, including ADAPT Panel™ and PTS-ID™.
Facilitates neuropsychiatric biomarker development using genomic data.
Enables objective mental health evaluations through biology-based methods.
People of Polaris Genomics
Unlock access to complete
Unlock access to complete
Funding Insights of Polaris Genomics
Polaris Genomics has successfully raised a total of $800K across 8 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $250 thousand completed in August 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Polaris Genomics
Polaris Genomics has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Illumina and Sanford Health.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Operator of integrated healthcare system providing medical services and health plans
|
Locked | Locked | Locked | |
|
Developer of technologies for analysis of genetic variation and function
|
Locked | Locked | Locked |
Investor details for Polaris Genomics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Polaris Genomics
Investment portfolio details for Polaris Genomics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Polaris Genomics
Detailed financials for Polaris Genomics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Polaris Genomics Comparisons
Peer comparison for Polaris Genomics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Polaris Genomics
Polaris Genomics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Assurex Health, PierianDx, Treos Bio, Circular Genomics and Ignyta, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Personalized medication for neuropsychiatric conditions is guided by pharmacogenomics.
|
|
| Locked | Locked | Locked |
Genetic tests for individualized disease diagnosis are provided.
|
|
| Locked | Locked | Locked |
Developer of cancer vaccines and companion diagnostics
|
|
| Locked | Locked | Locked |
RNA-based diagnostics and therapeutics for depression are developed and provided.
|
|
| Locked | Locked | Locked |
Personalized medicine is developed for cancer and autoimmune diseases.
|
|
| Locked | Locked | Locked |
Biological drug monitoring and molecular diagnostics are manufactured.
|
Detailed competitors of Polaris Genomics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Polaris Genomics
Complete news archive for Polaris Genomics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Polaris Genomics
Polaris Genomics was founded in 2017 and raised its 1st funding round 1 year after it was founded.
Polaris Genomics is headquartered in Rockville, United States. It is registered at Rockville, Maryland, United States.
Polaris Genomics is a funded company, having raised a total of $800K across 8 funding rounds to date.
Founded in 2017 and based in Rockville, United States, Polaris Genomics operates in the biotechnology sector with a focus on neurological conditions. Genomic-based diagnostics and therapeutics are developed using the proprietary TruNorth Platform for neuropsychiatric genomic analysis. PTS-ID, a genomic test for diagnosing and treating post-traumatic stress disorder, is also advanced by the company.
Polaris Genomics's top competitors include Assurex Health, Circular Genomics and PierianDx.
Polaris Genomics offers ADAPT Panel™ and PTS-ID™.
Polaris Genomics has 2 investors. Key investors include Illumina, and Sanford Health.